Overture Life
- Company typePrivate
- Founded2017
- HeadquartersAlcobendas, Spain
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
Overture Life firmographics
Firmographics- Name
- Overture Life
- Legal name
- Overture Life SLU
- Website
- https://overture.life
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Ownership category
- akta.pro rank
Overture Life industry classification
Industry- Product category
- IVF Automation / Reproductive Medical Devices
- NAICS
- Surgical Appliance and Supplies Manufacturing (339113), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening) (HLAAALAJ)
- akta.pro secondary industry
- Fertility, Reproductive Endocrinology & IVF Centers (HLAFAJAD)
Keywords
Where Overture Life is headquartered
LocationHeadquarters
- HQ city
- Alcobendas
- HQ country
- Spain
- HQ region
- Europe
Offices3 records
Markets served
Overture Life business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Operations, Personnel, Supply Chain, Marketing or Sales, Infrastructure
Revenue model
- DaVitri Platform Sales and Licensing: The company generates revenue through sale and licensing of its DaVitri automated vitrification platform to fertility clinics. The platform is deployed as a service-supported system, with clinics paying for access to the technology.
- MZ Metabolomics Testing Services: Revenue from non-invasive embryo assessment testing services performed at CLIA-licensed laboratories using mass spectrometry and machine learning to predict embryo viability.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels5 records
Overture Life product offering
Product offeringCore offering
Overture Life develops and commercializes automated hardware and consumable platforms for in vitro fertilization (IVF) laboratories. Its core products are DaVitri, an automated microfluidic vitrification platform for egg freezing and embryo warming; m/z, a non-invasive metabolomics embryo assessment test using mass spectrometry and machine learning; and ICSI, a robotic intracytoplasmic sperm injection system. These products are sold and licensed to fertility clinics to reduce operator-dependent variability, increase throughput, and lower infrastructure costs.
Product overview
Overture Life is an embryology automation company offering three core products: DaVitri (automated vitrification platform for egg freezing and embryo warming using microfluidic technology), m/z (non-invasive embryo assessment using metabolomics and machine learning), and ICSI (robotic sperm injection system). The company operates in Spain and the US with global expansion across Europe, UAE, India, and Brazil. Products are designed to automate complex IVF procedures, reduce costs, improve clinical outcomes, and enable fertility clinics to scale operations.
Differentiator
Problem solved
Functional benefit
Brands
- DaVitri: Automated vitrification platform for egg freezing and embryo warming using microfluidic technology
- MZ
- ICSI
Products and services
- DaVitri Automated vitrification platform that automates the egg-freezing and embryo-warming process through a microfluidic system. Demonstrates 12% improvement in egg survival rates and threefold throughput gains compared to manual methods. Regulatory cleared across US, Europe, South America, UAE, and India. Sold and licensed to fertility clinics seeking to standardize vitrification outcomes.
- m/z Non-invasive embryo assessment platform using metabolomics analysis of spent embryo culture media. Combines mass spectrometry with machine learning to predict embryo implantation with 85% accuracy, offering an alternative to traditional PGT-A testing methods. Performed as a service at CLIA-licensed laboratories for fertility clinics and IVF centers.
- ICSI Robotic intracytoplasmic sperm injection platform enabling automated sperm injection procedures as part of the IVF process. Part of Overture Life's portfolio of automated embryology solutions targeting fertility clinics.
Quantifiable outcome
- 12% improvement in egg survival rates with DaVitri platform
- +3 more outcomes
Companies that use Overture Life
Customer profileSegments1 record
Ideal customer profiles2 records
Overture Life technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability2 records
Overture Life partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Emitac Healthcare SolutionscoreOverture Life and Emitac Healthcare Solutions partnership aims to address operator-dependent variability in embryology procedures and enable UAE clinics to scale advanced fertility services while reducing infrastructure costs.
Scale indicators3 records
Recent moves6 records
Expansion highlights6 records
Overture Life competitors and assessment
Company assessmentDirect peers
- TMRW Life Sciences: TMRW Life Sciences provides automated cryostorage for eggs and embryos in IVF, making it the closest direct competitor to Overture's DaVitri automated vitrification platform. Both companies are pursuing software-and-robotic automation of IVF lab workflows with similar regulatory and clinic-adoption pathways.
- Hamilton Thorne: Hamilton Thorne manufactures precision instruments and automation for the IVF and animal breeding markets, including laser systems and embryo/vitrification devices. It directly competes with Overture in the embryology lab equipment category serving fertility clinics globally.
- Genea Biomedx: Genea Biomedx (the device arm of Genea) develops IVF lab automation and consumables including time-lapse incubators and culture systems. It targets the same fertility clinic automation category as Overture's DaVitri and ICSI platforms.
Broad incumbents
- Vitrolife: Vitrolife is a publicly traded global leader in IVF media, consumables, and time-lapse incubation systems. It overlaps with Overture across the embryology lab workflow but offers a much broader portfolio rather than specializing in automation.
- CooperSurgical: CooperSurgical provides a broad portfolio of fertility, genomics, and women's health products including IVF lab equipment, microtools, and genetic testing. It is an incumbent that competes across multiple IVF categories Overture serves.
- FUJIFILM Irvine Scientific: FUJIFILM Irvine Scientific supplies cell culture media, IVF products, and biorepository solutions to the assisted reproductive technology market. It is a broad incumbent in embryology lab consumables and adjacent equipment categories.
Others
- Progyny: Progyny is a fertility benefits management company that channels employer-sponsored patients to IVF clinics. While not a technology competitor, it shapes demand dynamics for IVF automation tools like DaVitri and is thematically adjacent to the fertility ecosystem Overture serves.
- Natera: Natera provides reproductive genetic testing including PGT-A and NIPT services to IVF clinics and patients. Its preimplantation genetic testing product competes with Overture's MZ metabolomics embryo assessment platform as an alternative embryo selection modality.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Overture Life social profiles
Digital presenceOverture Life compliance and trust
Trust signalCompliance4 records
Overture Life financial estimates
Financial estimateRevenue estimate
Valuation estimate
Overture Life leadership team
Management profileNumber of profiles
Profiles8 records
Overture Life funding detail
Funding detailFunding overview
Funding rounds6 records
Investors11 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Overture Life M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Overture Life
What does Overture Life do?
Overture Life develops and commercializes automated hardware and consumable platforms for in vitro fertilization (IVF) laboratories. Its core products are DaVitri, an automated microfluidic vitrification platform for egg freezing and embryo warming; m/z, a non-invasive metabolomics embryo assessment test using mass spectrometry and machine learning; and ICSI, a robotic intracytoplasmic sperm injection system. These products are sold and licensed to fertility clinics to reduce operator-dependent variability, increase throughput, and lower infrastructure costs.
Is Overture Life a public or private company?
Overture Life is a private company. It is classified as venture growth investor backed and is currently operating.
When was Overture Life founded?
Overture Life was founded in 2017. It employs 51 to 100 people.
Where is Overture Life based?
Overture Life is headquartered in Alcobendas, Spain, in the Europe region.
How does Overture Life make money?
Two revenue lines are on record. DaVitri Platform Sales and Licensing is the primary driver. The others are MZ Metabolomics Testing Services.
Who are Overture Life's main competitors?
Direct peers on record are TMRW Life Sciences, Hamilton Thorne and Genea Biomedx. Broad incumbents are Vitrolife, CooperSurgical and FUJIFILM Irvine Scientific. Others are Progyny and Natera.
Does Overture Life have an API?
No public API is recorded for Overture Life.
What industry is Overture Life in?
Overture Life's product category is IVF Automation / Reproductive Medical Devices. Its primary akta.pro industry code is HLAAALAJ, Prenatal, Newborn & Reproductive Diagnostics (NIPT, IVF/PGT, newborn screening), with a secondary code of HLAFAJAD, Fertility, Reproductive Endocrinology & IVF Centers. Its NAICS code is 339113 and its SIC code is 3841.